Clinical development and approval of COVID-19 vaccines-Reference-Cited by-同舟云学术

Clinical development and approval of COVID-19 vaccines

Published:2022-03-14 Issue:5 Volume:21 Page:609-619
ISSN:1476-0584
Container-title:Expert Review of Vaccines
language:en
Short-container-title:Expert Review of Vaccines

Author:

Kalinke Ulrich¹²,Barouch Dan H.³,Rizzi Ruben⁴,Lagkadinou Eleni⁴,Türeci Özlem⁴,Pather Shanti⁴,Neels Pieter⁵

Affiliation:

1. Institute for Experimental Infection Research, TWINCORE, Centre for Experimental and Clinical Infection Research, a joint venture between the Helmholtz Centre for Infection Research and the Hannover Medical School, Hannover, Germany

2. Cluster of Excellence - Resolving Infection Susceptibility (Resist, Exc 2155), Hannover Medical School, Hannover, Germany

3. Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA

4. BioNTech SE, Mainz, Germany

5. Vaccine Advice BV, Belgium

Funder

Medical Communications agency Scion

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,Molecular Medicine,Immunology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14760584.2022.2042257

Reference99 articles.

1. World Health Organization. Coronavirus Disease (COVID-19). Press Conference, 28 February 2020 [Internet]. [cited 2022 Feb 10]. Available from: https://www.who.int/docs/default-source/coronaviruse/transcripts/who-audio-emergencies-coronavirus-press-conference-full-28feb2020.pdf?sfvrsn=13eeb6a4_2

2. World Health Organization. WHO director-general’s opening remarks at the media briefing on COVID-19 - 11 March 2020 [Internet]. [cited 2022 Feb 10]. Available from: https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19—11-march-2020

3. Evolution of the COVID-19 vaccine development landscape

4. US Food and Drug Administration. Emergency Use Authorization (EUA) for an unapproved product review memorandum. Application 27034 [Internet]. [cited 2022 Feb 10]. Available from: https://www.fda.gov/media/144416/download

5. US Food and Drug Administration. Emergency Use Authorization (EUA) for an unapproved product review memorandum. Application 27073 [Internet]. [cited 2022 Feb 10]. Available from: https://fda.report/media/144673/Moderna+COVID-19+Vaccine+review+memo.pdf

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. mRNA vaccines;mRNA Therapeutics;2025

2. Vaccine efficacy, safety, and regulatory controls;mRNA Therapeutics;2025

3. A Brighton Collaboration standardized template with key considerations for a benefit-risk assessment for the Comirnaty COVID-19 mRNA vaccine;Vaccine;2024-09

4. Discovering vaccines: the trial tale;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-08-23

5. RNA therapeutics to control fibrinolysis: review on applications in biology and medicine;Journal of Thrombosis and Haemostasis;2024-08